More recently, we have found that the sod2 promoter is methylated in some multiple myeloma cells and diminished expression can be reversed by the methyltransferase inhibitor zebularine (Hodge et al, 2005a), suggesting that repression of SOD2 may occur at the level of epigenetic regulation. This evidence concerns the gene SOD2 and AL amyloidosis.